Consainsights logo
Life Sciences

Myasthenia Gravis Therapeutics Market

Treatment, End-User.
License Type
What you get?
  • Online view only
  • Delivered in 24-72 hours
  • Only a single designated user can access the report
  • 5 hours of analyst support

Executive Summary

Myasthenia Gravis Therapeutics Market from Consainsights analyses the Myasthenia Gravis Therapeutics Market in the Technology & Media industry over the forecast period to 2026.

Myasthenia Gravis Therapeutics research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Myasthenia Gravis Therapeutics segmentation includes End-User, Treatment and Geography.

All segmentations encompasses the key innovations and micro & macro trends, companies/manufacturers operating in this space along with their usage and penetration with respect to the wide range of End Users. Additionally, market sizing information along with the key factors such as market drivers, restraints, opportunities and challenges which are likely to be influencing the market growth are outlined in this report.

Based on the End-User, the Myasthenia Gravis Therapeutics Market analysis covers Clinics, Hospitals, Others.

Based on the Treatment, the Myasthenia Gravis Therapeutics Market analysis covers Medication, Others, Surgery.

Key companies operating in the market include UCB Pharma, Grifols SA, CuraVac, Bausch Health, Argenx, Mitsubishi Tanabe Pharma, Alexion Pharmaceutical Inc., Novartis, Immunovant, Astellas Pharma and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Moreover, the competitive analysis includes the companies deals such as Mergers, Acquisitions, Partnerships and so on along with the expansion areas focusing on the additional geographies, future insights for success and market share analysis. Major players strategies include the launch of the innovative product lines along with the emphasis on the partnerships and acquisitions to standardize their market share in the market space.

Market Research methodology includes the triangulation of the data from the data sources such as Primary Market Research approach and Secondary Market Research Approach along with the data from the trade bodies and industry standard publications and data sources. Primary inputs from the industry experts and the market respondents from the respective industries to obtain very critical information to assess the future growth prospects of the market. The final data is triangulated and thoroughly validated considering all the data sources using the bottom-up and the top-down approaches to estimate the market sizing of the individual segments.

Report Metric

Details

Market size available for years

2012-2027

Base year considered

2021

Forecast period

2022-2027

Forecast units

Value (USD Billion)

Segments covered

End-User, Treatment

Geographies covered

North America, Europe, Asia-Pacific, Latin America, Middle East & Africa

Companies Covered

UCB Pharma, Grifols SA, CuraVac, Bausch Health, Argenx, Mitsubishi Tanabe Pharma, Alexion Pharmaceutical Inc., Novartis, Immunovant, Astellas Pharma


Table of Contents

  1. Executive Summary

  2. Myasthenia Gravis Therapeutics Market Overview

    1. Myasthenia Gravis Therapeutics Market Definition & Scope
    2. Currency, Year and Forecasts Overview
    3. Myasthenia Gravis Therapeutics Market 360° Synopsis: Overview
  3. Myasthenia Gravis Therapeutics Industry Analysis

    1. Industry Value Chain Analysis
    2. Key Companies at each phase of Value Chain
    3. Industry Trend Analysis
  4. Myasthenia Gravis Therapeutics Market Analysis

    1. Drives, Restraints, Opportunities and Challenges Impact Analysis
    2. Porter’s Five Force Model Analysis
    3. PESTLE Analysis
    4. BPS Analysis
    5. Myasthenia Gravis Therapeutics Market Key Innovation & Trends
    6. Pricing Patterns (Company & Product Type)
  5. Myasthenia Gravis Therapeutics Market: End-User

    1. Introduction
    2. Clinics: Market Trends, Size, and Forecast (2017-2026)
    3. Hospitals: Market Trends, Size, and Forecast (2017-2026)
    4. Others: Market Trends, Size, and Forecast (2017-2026)
  6. Myasthenia Gravis Therapeutics Market: Treatment

    1. Introduction
    2. Medication: Market Trends, Size, and Forecast (2017-2026)
    3. Others: Market Trends, Size, and Forecast (2017-2026)
    4. Surgery: Market Trends, Size, and Forecast (2017-2026)
  7. Global Analysis

    1. Global Myasthenia Gravis Therapeutics Market, By Region, Y-O-Y Growth Analysis

      1. Introduction
      2. North America: Market Trends, Size, and Forecast (2017-2026)
      3. Europe: Market Trends, Size, and Forecast (2017-2026)
      4. Asia-Pacific: Market Trends, Size, and Forecast (2017-2026)
      5. Latin America: Market Trends, Size, and Forecast (2017-2026)
      6. Middle East & Africa: Market Trends, Size, and Forecast (2017-2026)
  8. North America Analysis

    1. North America Myasthenia Gravis Therapeutics Market, By Country, Y-O-Y Growth Analysis

      1. Introduction
      2. United States: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. United States Myasthenia Gravis Therapeutics Market: End-User
        3. United States Myasthenia Gravis Therapeutics Market: Treatment
      3. Canada: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Canada Myasthenia Gravis Therapeutics Market: End-User
        3. Canada Myasthenia Gravis Therapeutics Market: Treatment
    2. North America Myasthenia Gravis Therapeutics Market, By End-User, Y-O-Y Growth Analysis

      1. Introduction
      2. Clinics: Market Trends, Size, and Forecast (2017-2026)
      3. Hospitals: Market Trends, Size, and Forecast (2017-2026)
      4. Others: Market Trends, Size, and Forecast (2017-2026)
    3. North America Myasthenia Gravis Therapeutics Market, By Treatment, Y-O-Y Growth Analysis

      1. Introduction
      2. Medication: Market Trends, Size, and Forecast (2017-2026)
      3. Others: Market Trends, Size, and Forecast (2017-2026)
      4. Surgery: Market Trends, Size, and Forecast (2017-2026)
  9. Europe Analysis

    1. Europe Myasthenia Gravis Therapeutics Market, By Country, Y-O-Y Growth Analysis

      1. Introduction
      2. Germany: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Germany Myasthenia Gravis Therapeutics Market: End-User
        3. Germany Myasthenia Gravis Therapeutics Market: Treatment
      3. United Kingdom: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. United Kingdom Myasthenia Gravis Therapeutics Market: End-User
        3. United Kingdom Myasthenia Gravis Therapeutics Market: Treatment
      4. France: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. France Myasthenia Gravis Therapeutics Market: End-User
        3. France Myasthenia Gravis Therapeutics Market: Treatment
      5. Spain: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Spain Myasthenia Gravis Therapeutics Market: End-User
        3. Spain Myasthenia Gravis Therapeutics Market: Treatment
      6. Russia: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Russia Myasthenia Gravis Therapeutics Market: End-User
        3. Russia Myasthenia Gravis Therapeutics Market: Treatment
      7. Italy: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Italy Myasthenia Gravis Therapeutics Market: End-User
        3. Italy Myasthenia Gravis Therapeutics Market: Treatment
      8. Rest of Europe: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Rest of Europe Myasthenia Gravis Therapeutics Market: End-User
        3. Rest of Europe Myasthenia Gravis Therapeutics Market: Treatment
    2. Europe Myasthenia Gravis Therapeutics Market, By End-User, Y-O-Y Growth Analysis

      1. Introduction
      2. Clinics: Market Trends, Size, and Forecast (2017-2026)
      3. Hospitals: Market Trends, Size, and Forecast (2017-2026)
      4. Others: Market Trends, Size, and Forecast (2017-2026)
    3. Europe Myasthenia Gravis Therapeutics Market, By Treatment, Y-O-Y Growth Analysis

      1. Introduction
      2. Medication: Market Trends, Size, and Forecast (2017-2026)
      3. Others: Market Trends, Size, and Forecast (2017-2026)
      4. Surgery: Market Trends, Size, and Forecast (2017-2026)
  10. Asia-Pacific Analysis

    1. Asia-Pacific Myasthenia Gravis Therapeutics Market, By Country, Y-O-Y Growth Analysis

      1. Introduction
      2. China: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. China Myasthenia Gravis Therapeutics Market: End-User
        3. China Myasthenia Gravis Therapeutics Market: Treatment
      3. Japan: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Japan Myasthenia Gravis Therapeutics Market: End-User
        3. Japan Myasthenia Gravis Therapeutics Market: Treatment
      4. India: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. India Myasthenia Gravis Therapeutics Market: End-User
        3. India Myasthenia Gravis Therapeutics Market: Treatment
      5. Southeast Asia: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Southeast Asia Myasthenia Gravis Therapeutics Market: End-User
        3. Southeast Asia Myasthenia Gravis Therapeutics Market: Treatment
      6. Australia & New Zealand: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Australia & New Zealand Myasthenia Gravis Therapeutics Market: End-User
        3. Australia & New Zealand Myasthenia Gravis Therapeutics Market: Treatment
      7. Rest of Asia-Pacific: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Rest of Asia-Pacific Myasthenia Gravis Therapeutics Market: End-User
        3. Rest of Asia-Pacific Myasthenia Gravis Therapeutics Market: Treatment
    2. Asia-Pacific Myasthenia Gravis Therapeutics Market, By End-User, Y-O-Y Growth Analysis

      1. Introduction
      2. Clinics: Market Trends, Size, and Forecast (2017-2026)
      3. Hospitals: Market Trends, Size, and Forecast (2017-2026)
      4. Others: Market Trends, Size, and Forecast (2017-2026)
    3. Asia-Pacific Myasthenia Gravis Therapeutics Market, By Treatment, Y-O-Y Growth Analysis

      1. Introduction
      2. Medication: Market Trends, Size, and Forecast (2017-2026)
      3. Others: Market Trends, Size, and Forecast (2017-2026)
      4. Surgery: Market Trends, Size, and Forecast (2017-2026)
  11. Middle East & Africa Analysis

    1. Middle East & Africa Myasthenia Gravis Therapeutics Market, By Country, Y-O-Y Growth Analysis

      1. Introduction
      2. Middle East: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Middle East Myasthenia Gravis Therapeutics Market: End-User
        3. Middle East Myasthenia Gravis Therapeutics Market: Treatment
      3. Africa: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Africa Myasthenia Gravis Therapeutics Market: End-User
        3. Africa Myasthenia Gravis Therapeutics Market: Treatment
      4. Rest of Middle East & Africa: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Rest of Middle East & Africa Myasthenia Gravis Therapeutics Market: End-User
        3. Rest of Middle East & Africa Myasthenia Gravis Therapeutics Market: Treatment
    2. Middle East & Africa Myasthenia Gravis Therapeutics Market, By End-User, Y-O-Y Growth Analysis

      1. Introduction
      2. Clinics: Market Trends, Size, and Forecast (2017-2026)
      3. Hospitals: Market Trends, Size, and Forecast (2017-2026)
      4. Others: Market Trends, Size, and Forecast (2017-2026)
    3. Middle East & Africa Myasthenia Gravis Therapeutics Market, By Treatment, Y-O-Y Growth Analysis

      1. Introduction
      2. Medication: Market Trends, Size, and Forecast (2017-2026)
      3. Others: Market Trends, Size, and Forecast (2017-2026)
      4. Surgery: Market Trends, Size, and Forecast (2017-2026)
  12. Latin America Analysis

    1. Latin America Myasthenia Gravis Therapeutics Market, By Country, Y-O-Y Growth Analysis

      1. Introduction
      2. Brazil: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Brazil Myasthenia Gravis Therapeutics Market: End-User
        3. Brazil Myasthenia Gravis Therapeutics Market: Treatment
      3. Argentina: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Argentina Myasthenia Gravis Therapeutics Market: End-User
        3. Argentina Myasthenia Gravis Therapeutics Market: Treatment
      4. Mexico: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Mexico Myasthenia Gravis Therapeutics Market: End-User
        3. Mexico Myasthenia Gravis Therapeutics Market: Treatment
      5. Colombia: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Colombia Myasthenia Gravis Therapeutics Market: End-User
        3. Colombia Myasthenia Gravis Therapeutics Market: Treatment
      6. Rest of Latin America: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Rest of Latin America Myasthenia Gravis Therapeutics Market: End-User
        3. Rest of Latin America Myasthenia Gravis Therapeutics Market: Treatment
    2. Latin America Myasthenia Gravis Therapeutics Market, By End-User, Y-O-Y Growth Analysis

      1. Introduction
      2. Clinics: Market Trends, Size, and Forecast (2017-2026)
      3. Hospitals: Market Trends, Size, and Forecast (2017-2026)
      4. Others: Market Trends, Size, and Forecast (2017-2026)
    3. Latin America Myasthenia Gravis Therapeutics Market, By Treatment, Y-O-Y Growth Analysis

      1. Introduction
      2. Medication: Market Trends, Size, and Forecast (2017-2026)
      3. Others: Market Trends, Size, and Forecast (2017-2026)
      4. Surgery: Market Trends, Size, and Forecast (2017-2026)
  13. Myasthenia Gravis Therapeutics Market: Company Analysis

    1. Introduction
    2. UCB Pharma

      1. Overview
      2. Business Portfolio
      3. Product Portfolio
      4. Key Brands Insights
      5. Company SWOT & Strategic Analysis
      6. Company Financials
      7. Analyst Insights
    3. Grifols SA

    4. CuraVac

    5. Bausch Health

    6. Argenx

    7. Mitsubishi Tanabe Pharma

    8. Alexion Pharmaceutical Inc.

    9. Novartis

    10. Immunovant

    11. Astellas Pharma

  14. Myasthenia Gravis Therapeutics Market: Competitive Analysis

    1. Strategic Dashboard of Top Market Players
    2. Companies Deals (Mergers, Partnerships, Acquisitions, JVs)
    3. Expansion Areas (Based on Company Analysis)
    4. Market Share Analysis
  15. Myasthenia Gravis Therapeutics Market: Distribution Channel Analysis

    1. Distributor Type Analysis
    2. Major Distributors (Key Countries)
    3. Future Growth Prospects
  16. Industry & Analysts Insights for Success

  17. Research Methodology

  18. Appendix

    1. List of Tables
    2. List of Figures
    3. Available Customizations
    4. Related Reports

List of Figures & Tables

List of Figures

Figure: Global Myasthenia Gravis Therapeutics Market: Structure

Figure: Global Myasthenia Gravis Therapeutics Market: Value Chain Analysis

Figure: Global Myasthenia Gravis Therapeutics Market: Porter's Five Forces Model

Figure: Global Myasthenia Gravis Therapeutics Market: Market Dynamics

Figure: Global Myasthenia Gravis Therapeutics Market, By Myasthenia Gravis Therapeutics, 2022-2027 (USD Million)

Figure: North America Myasthenia Gravis Therapeutics Market, By Myasthenia Gravis Therapeutics, 2022-2027 (USD Million)

Figure: Europe Myasthenia Gravis Therapeutics Market, By Myasthenia Gravis Therapeutics, 2022-2027 (USD Million)

Figure: Asia-Pacific Myasthenia Gravis Therapeutics Market, By Myasthenia Gravis Therapeutics, 2022-2027 (USD Million)

Figure: Latin America Myasthenia Gravis Therapeutics Market, By Myasthenia Gravis Therapeutics, 2022-2027 (USD Million)

Figure: Middle East & Africa Myasthenia Gravis Therapeutics Market, By Myasthenia Gravis Therapeutics, 2022-2027 (USD Million)

Figure: Global Myasthenia Gravis Therapeutics Market, By Myasthenia Gravis Therapeutics, 2022-2027 (USD Million)

Figure: North America Myasthenia Gravis Therapeutics Market, By Myasthenia Gravis Therapeutics, 2022-2027 (USD Million)

Figure: Europe Myasthenia Gravis Therapeutics Market, By Myasthenia Gravis Therapeutics, 2022-2027 (USD Million)

Figure: Asia-Pacific Myasthenia Gravis Therapeutics Market, By Myasthenia Gravis Therapeutics, 2022-2027 (USD Million)

Figure: Latin America Myasthenia Gravis Therapeutics Market, By Myasthenia Gravis Therapeutics, 2022-2027 (USD Million)

Figure: Middle East & Africa Myasthenia Gravis Therapeutics Market, By Myasthenia Gravis Therapeutics, 2022-2027 (USD Million)

List of Tables

Table: Global Myasthenia Gravis Therapeutics Market, By End-User, 2017-2026 (USD Million)

Table: North America Myasthenia Gravis Therapeutics Market, By End-User, 2022-2027 (USD Million)

Table: United States Myasthenia Gravis Therapeutics Market, By End-User, 2022-2027 (USD Million)

Table: Canada Myasthenia Gravis Therapeutics Market, By End-User, 2022-2027 (USD Million)

Table: Europe Myasthenia Gravis Therapeutics Market, By End-User, 2022-2027 (USD Million)

Table: Germany Myasthenia Gravis Therapeutics Market, By End-User, 2022-2027 (USD Million)

Table: United Kingdom Myasthenia Gravis Therapeutics Market, By End-User, 2022-2027 (USD Million)

Table: France Myasthenia Gravis Therapeutics Market, By End-User, 2022-2027 (USD Million)

Table: Spain Myasthenia Gravis Therapeutics Market, By End-User, 2022-2027 (USD Million)

Table: Russia Myasthenia Gravis Therapeutics Market, By End-User, 2022-2027 (USD Million)

Table: Italy Myasthenia Gravis Therapeutics Market, By End-User, 2022-2027 (USD Million)

Table: Rest of Europe Myasthenia Gravis Therapeutics Market, By End-User, 2022-2027 (USD Million)

Table: Asia-Pacific Myasthenia Gravis Therapeutics Market, By End-User, 2022-2027 (USD Million)

Table: China Myasthenia Gravis Therapeutics Market, By End-User, 2022-2027 (USD Million)

Table: Japan Myasthenia Gravis Therapeutics Market, By End-User, 2022-2027 (USD Million)

Table: India Myasthenia Gravis Therapeutics Market, By End-User, 2022-2027 (USD Million)

Table: Southeast Asia Myasthenia Gravis Therapeutics Market, By End-User, 2022-2027 (USD Million)

Table: Australia & New Zealand Myasthenia Gravis Therapeutics Market, By End-User, 2022-2027 (USD Million)

Table: Rest of Asia-Pacific Myasthenia Gravis Therapeutics Market, By End-User, 2022-2027 (USD Million)

Table: Latin America Myasthenia Gravis Therapeutics Market, By End-User, 2022-2027 (USD Million)

Table: Brazil Myasthenia Gravis Therapeutics Market, By End-User, 2022-2027 (USD Million)

Table: Argentina Myasthenia Gravis Therapeutics Market, By End-User, 2022-2027 (USD Million)

Table: Mexico Myasthenia Gravis Therapeutics Market, By End-User, 2022-2027 (USD Million)

Table: Colombia Myasthenia Gravis Therapeutics Market, By End-User, 2022-2027 (USD Million)

Table: Rest of Latin America Myasthenia Gravis Therapeutics Market, By End-User, 2022-2027 (USD Million)

Table: Middle East & Africa Myasthenia Gravis Therapeutics Market, By End-User, 2022-2027 (USD Million)

Table: Middle East Myasthenia Gravis Therapeutics Market, By End-User, 2022-2027 (USD Million)

Table: Africa Myasthenia Gravis Therapeutics Market, By End-User, 2022-2027 (USD Million)

Table: Rest of Middle East & Africa Myasthenia Gravis Therapeutics Market, By End-User, 2022-2027 (USD Million)

Table: Global Myasthenia Gravis Therapeutics Market, By Treatment, 2017-2026 (USD Million)

Table: North America Myasthenia Gravis Therapeutics Market, By Treatment, 2022-2027 (USD Million)

Table: United States Myasthenia Gravis Therapeutics Market, By Treatment, 2022-2027 (USD Million)

Table: Canada Myasthenia Gravis Therapeutics Market, By Treatment, 2022-2027 (USD Million)

Table: Europe Myasthenia Gravis Therapeutics Market, By Treatment, 2022-2027 (USD Million)

Table: Germany Myasthenia Gravis Therapeutics Market, By Treatment, 2022-2027 (USD Million)

Table: United Kingdom Myasthenia Gravis Therapeutics Market, By Treatment, 2022-2027 (USD Million)

Table: France Myasthenia Gravis Therapeutics Market, By Treatment, 2022-2027 (USD Million)

Table: Spain Myasthenia Gravis Therapeutics Market, By Treatment, 2022-2027 (USD Million)

Table: Russia Myasthenia Gravis Therapeutics Market, By Treatment, 2022-2027 (USD Million)

Table: Italy Myasthenia Gravis Therapeutics Market, By Treatment, 2022-2027 (USD Million)

Table: Rest of Europe Myasthenia Gravis Therapeutics Market, By Treatment, 2022-2027 (USD Million)

Table: Asia-Pacific Myasthenia Gravis Therapeutics Market, By Treatment, 2022-2027 (USD Million)

Table: China Myasthenia Gravis Therapeutics Market, By Treatment, 2022-2027 (USD Million)

Table: Japan Myasthenia Gravis Therapeutics Market, By Treatment, 2022-2027 (USD Million)

Table: India Myasthenia Gravis Therapeutics Market, By Treatment, 2022-2027 (USD Million)

Table: Southeast Asia Myasthenia Gravis Therapeutics Market, By Treatment, 2022-2027 (USD Million)

Table: Australia & New Zealand Myasthenia Gravis Therapeutics Market, By Treatment, 2022-2027 (USD Million)

Table: Rest of Asia-Pacific Myasthenia Gravis Therapeutics Market, By Treatment, 2022-2027 (USD Million)

Table: Latin America Myasthenia Gravis Therapeutics Market, By Treatment, 2022-2027 (USD Million)

Table: Brazil Myasthenia Gravis Therapeutics Market, By Treatment, 2022-2027 (USD Million)

Table: Argentina Myasthenia Gravis Therapeutics Market, By Treatment, 2022-2027 (USD Million)

Table: Mexico Myasthenia Gravis Therapeutics Market, By Treatment, 2022-2027 (USD Million)

Table: Colombia Myasthenia Gravis Therapeutics Market, By Treatment, 2022-2027 (USD Million)

Table: Rest of Latin America Myasthenia Gravis Therapeutics Market, By Treatment, 2022-2027 (USD Million)

Table: Middle East & Africa Myasthenia Gravis Therapeutics Market, By Treatment, 2022-2027 (USD Million)

Table: Middle East Myasthenia Gravis Therapeutics Market, By Treatment, 2022-2027 (USD Million)

Table: Africa Myasthenia Gravis Therapeutics Market, By Treatment, 2022-2027 (USD Million)

Table: Rest of Middle East & Africa Myasthenia Gravis Therapeutics Market, By Treatment, 2022-2027 (USD Million)